Skip to content

Management of Obstructive Colon Tumors in Istanbul

Management of Obstructive Colon Tumors in Istanbul: Multicenter Prospective Observational Cohort

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05424939
Enrollment
500
Registered
2022-06-21
Start date
2022-06-01
Completion date
2024-05-31
Last updated
2022-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Emergencies, Quality of Life, Tumor Obstruction

Brief summary

The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.

Interventions

PROCEDUREColectomy

Colon resection

PROCEDUREStoma procedures

Any type of colostomy or ileostomy with or without bowel resection

PROCEDUREBy-pass/laparotomy/laparoscopy/biopsy

Any palliative surgery without bowel resection

Sponsors

Istanbul Medipol University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Acute intestinal obstruction due to colon cancer either preoperatively or intraoperatively detected * Clinical findings of obstruction (Abdominal distention and pain, nausea or vomiting, and absence of bowel movements) confirmed by abdominal x-ray or CT

Exclusion criteria

* Benign diseases * Emergency surgery due to bleeding, perforation and other non-obstructive situations * Recurrent colon tumors * Rectal cancer

Design outcomes

Primary

MeasureTime frameDescription
Time-to-starting chemotherapy1 yearSurgical procedures will be compared in terms of days-to-first chemotherapy

Secondary

MeasureTime frameDescription
Mortality3 months90-day mortality
Morbidity3 months90-day morbidity
Colorectal cancer-specific quality of life (EORTC QLQ - CR29) at 1 year1 yearThe European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire-Colorectal Cancer (EORTC QLQ-CR29) scale will be recorded preoperatively and at 12 months. Surgical procedures will be compared in terms of improvement in EORTC QLQ-CR29 scores.

Countries

Turkey (Türkiye)

Contacts

Primary ContactNaciye Cigdem Arslan, MD
cigdemarslan@hotmail.it+90 531 389 09 75

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026